focus -WSS

focus

author：knowledge 2025-08-24 23:09:06 - browse：5

Exact Sciences headquarters. -- biotech coverage from STAT — Exact Sciences' headquarters in Madison, Wis. Wikimedia Commons

Exact Sciences reported first-quarter revenues this week that beat market expectations, and the cancer detection company’s executives still believe they’re on track to meet expected 2024 revenue.

That’s usually good news. Yet Exact shares are down nearly 11% on Thursday, dipping to $53.12 within the first few hours of trading. During after-hours trading on Wednesday, shortly after Exact released its financial updates, shares tumbled as low as $47.24.

The seemingly paradoxical result reflects worries about a potential slowdown in future growth at Exact, a $10 billion biotech best known for Cologuard, a colon cancer screening test that detects blood and DNA from stool samples. The test, which first won regulatory approval in 2014, was designed to boost cancer screening rates by providing a more convenient alternative to colonoscopies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： When is a doctor not a doctor? Try when patients address women doctors

WSS

Lawsuit challenges CMS nursing home minimum staffing rule

Asahi Kasei to buy Calliditas, picking up kidney disease drug

Beyond aggravation: Constipation is an American epidemic

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

Some medical students still think black patients feel less pain

Pfizer's Covid pill remains 89% effective in final analysis, company says

focus

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Wikipedia

What does generative AI mean for health care? We asked experts

Van's Gluten Free Original Waffles recalled for possible wheat allergen

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Protect nursing home residents from future pandemics

Continuity nursing helped my family in our darkest PICU moments

4th of July breaks record for highest global temperature ever measured

Hollywood unions extend contract negotiations for actors

Connecting traumatic brain injury and domestic violence

Drug repurposing or repositioning? The language matters

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

leisure time

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

Australia's humpback populations rebound raising hopes of marine scientists

Louisiana bill approved classifying abortion pills as controlled substances

PhRMA sues HHS over Medicare drug price negotiation

Why some fertility treatments produce more boy babies

Achieving telehealth equity for people with hearing loss

focus

hotspot

leisure time

Wikipedia